Nifty 17053.95 (0.16%)
Sensex 57260.58 (0.27%)
Nifty Bank 35976.45 (-0.14%)
Nifty IT 34870.75 (0.76%)
Nifty Financial Services 17629.95 (0.09%)
Adani Ports 702.60 (-2.03%)
Asian Paints 3144.30 (0.04%)
Axis Bank 651.10 (-1.61%)
B P C L 367.45 (-2.49%)
Bajaj Auto 3298.20 (-1.09%)
Bajaj Finance 6905.75 (1.45%)
Bajaj Finserv 16890.40 (1.25%)
Bharti Airtel 739.35 (0.08%)
Britannia Inds. 3528.60 (-0.75%)
Cipla 965.00 (-0.18%)
Coal India 154.25 (-1.06%)
Divis Lab. 4921.35 (-0.33%)
Dr Reddys Labs 4697.60 (-1.12%)
Eicher Motors 2413.40 (-0.84%)
Grasim Inds 1683.95 (-0.36%)
H D F C 2713.80 (-1.02%)
HCL Technologies 1133.15 (2.08%)
HDFC Bank 1501.25 (0.76%)
HDFC Life Insur. 683.65 (1.94%)
Hero Motocorp 2490.80 (-1.53%)
Hind. Unilever 2329.40 (-0.24%)
Hindalco Inds. 420.15 (0.76%)
I O C L 118.80 (-1.78%)
ICICI Bank 718.40 (-0.53%)
IndusInd Bank 895.45 (-0.70%)
Infosys 1696.35 (0.28%)
ITC 221.50 (-1.12%)
JSW Steel 625.60 (-0.49%)
Kotak Mah. Bank 2019.60 (2.82%)
Larsen & Toubro 1767.25 (-0.61%)
M & M 850.80 (-0.35%)
Maruti Suzuki 7149.50 (-0.29%)
Nestle India 19000.40 (-1.15%)
NTPC 126.50 (-1.82%)
O N G C 144.10 (-2.04%)
Power Grid Corpn 200.25 (-0.87%)
Reliance Industr 2441.50 (1.20%)
SBI Life Insuran 1136.25 (0.52%)
Shree Cement 25540.05 (-1.56%)
St Bk of India 465.10 (-1.15%)
Sun Pharma.Inds. 751.05 (-2.12%)
Tata Consumer 766.00 (-0.09%)
Tata Motors 461.45 (0.27%)
Tata Steel 1114.75 (0.22%)
TCS 3502.00 (1.60%)
Tech Mahindra 1536.65 (0.61%)
Titan Company 2324.20 (1.39%)
UltraTech Cem. 7388.25 (-0.09%)
UPL 689.35 (-2.05%)
Wipro 630.60 (1.47%)
INFY

Parenteral Drugs (India) ..

₹4.3
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Parenteral Drugs

  • Master Rating:
  • Parenteral Drugs India has an operating revenue of Rs. 9.89 Cr. on a trailing 12-month basis. An annual revenue de-growth of -62% needs improvement, Pre-tax margin of -1270% needs improvement, NULL It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 49 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 147 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Parenteral Drugs (India) Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Parenteral Drugs (India) Ltd Synopsis

NSE-Medical-Diversified

Parenteral Drugs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 12.17 Cr. and Equity Capital is Rs. 29.82 Cr. for the Year ended 31/03/2021. Parenteral Drugs (India) Ltd. is a Public Limited Listed company incorporated on 13/12/1983 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1983PLC126481 and registration number is 126481.
  • Market Cap

    INR 12.82 Cr

  • Sales

    INR 9.89 Cr

  • Shares in Float

    0.81 Cr

  • No of Funds

    6 K

  • Yield

    %

  • Book Value

    -0.02

  • U/D Vol Ratio

    0.9

  • LTDebt/Equity

    %

  • Alpha

    0.86

  • Beta

    0.42

Parenteral Drugs (India) Ltd Ownership
Parenteral Drugs (India) Ltd Management

Parenteral Drugs (India) Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr -683.2004-561.63081-447.24889-31.0630963.22518
Fixed Assets Annual Cr 321.8141339.14065356.4865616.92383634.13228
Total Non Current Assets Annual Cr 499.4442483.70065472.5782699.58092692.905
Total Current Assets Annual Cr 67.347466.7387466.5784864.7452566.9344
Total Assets Annual Cr 566.7916550.43939539.15668764.32618759.8394
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs -188.363-150.001-36.146-3.91
ROE Annual % 0000
ROCE Annual % 6.9825.21-14.19-13.08
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % -96.22-45.27-50.64-43.98-61.33

Parenteral Drugs (India) Ltd Technicals

EMA & SMA

CURRENT PRICE

4.3 (0)

    • Bullish Moving Averages 16
    • Bearish Moving Averages 0

EMA

  • 20 Day

    3.63

  • 50 Day

    3.49

  • 100 Day

    3.39

  • 200 Day

    3.21

Parenteral Drugs (India) Ltd Resistance and support

4.3 PIVOT

  • First Resistance

    4.3

  • Second Resistance

    4.3

  • Third Resistance

    4.3

  • First Support

    4.3

  • Second Support

    4.3

  • Third Support

    4.3

  • RSI

    75.41

  • MFI

    100

  • MACD

    0.23

  • MACD signal line

    0.06

Parenteral Drugs (India) Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,060 206,000 100%
Week 2,060 206,000 100%
1 Month 0 0 %
6 Month 3,243 323,819 99.86%

Parenteral Drugs (India) Ltd Price change analysis

0.35

Over 1 month

Low High
4.1 5.41

0.41

Over 3 month

Low High
2.5 5.41

-0.15

Over 6 months

Low High
2.5 5.41

1.7

Over Year

Low High
2.5 5.41

Similar Stocks

News

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Announcement unde

Disclosure regarding publication of Unaudited Financial Results for the Quarter and half year ended on 30th September, 2021 in Newspaper Read More

Parenteral Drugs India Ltd - 524689 - Results-Financial Resu

Parenteral Drugs (India) Limited hereby submits Unaudited Financial Results on both Standalone and consolidated basis for the Quarter and ha Read More

PARENTERAL DRUGS (INDIA) LTD.-$ - 524689 - Board Meeting Out

Parenteral Drugs (India) Limited hereby submits Outcome of Board Meeting held on 12th November, 2021 Read More

Parenteral Drugs India Ltd - 524689 - Board Meeting Intimati

PARENTERAL DRUGS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter a Read More

Parenteral Drugs India Ltd - 524689 - Shareholding for the P

Parenteral Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly C Read More

Blogs

FAQs